NIH Consensus Response Criteria for Chronic GVHD

Known as: NIH Chronic GVHD Consensus Project Response Criteria, NIH Consensus Response Criteria for cGVHD, NIH cGVHD Consensus Project Response Criteria 
A tool used to assess response to therapy for chronic Graft versus Host Disease (cGVHD) based on clinical trial findings and recommended by the NIH… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2017
02419972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Allogeneic hematopoietic stem cell transplantation is hampered by chronic graft-versus-host disease (cGVHD), resulting in… (More)
Is this relevant?
2013
2013
Chronic GVHD (cGVHD) is the most important determinant of late morbidity and mortality in long-term survivors after allo-SCT… (More)
  • figure 1
  • table 1
Is this relevant?
2012
2012
We studied graft-versus-host disease (GVHD) on relapse, transplant-related mortality (TRM), disease-free survival (DFS), and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
Is this relevant?
2011
2011
This retrospective study analyzes 34 patients with severe sclerodermatous chronic graft-versus-host disease (cGVHD) treated with… (More)
  • table 2
  • table 1
  • table 3
  • table 4
  • figure 1
Is this relevant?
2008
2008
Treatment of sclerodermatous chronic GVHD (cGVHD) remains disappointing. Imatinib mesylate enables selective, dual inhibition of… (More)
  • table 1
  • figure 1
Is this relevant?
2007
2007
AIMS To analyse the histological features of 33 patients (48 biopsy specimens) with a clinicopathological diagnosis of graft vs… (More)
Is this relevant?
2007
2007
Extracorporeal photochemotherapy (ECP) is an alternative treatment approach in the management of chronic graft-versus-host… (More)
Is this relevant?
2005
2005
Nephrotic syndrome (NS) is an extremely rare complication of myeloablative allogeneic haematopoietic cell transplantation (HCT… (More)
Is this relevant?
2004
2004
Chronic graft-versus-host disease (cGVHD) affects 30–50% of hematopoietic stem cell transplant (HSCT) patients with skin… (More)
  • figure 1
  • figure 2
Is this relevant?
1997
1997
Ex vivo production of interleukin 10 (IL-10) and interferon-γ (IFN-γ) was investigated in patients with (n = 5) or without (n = 5… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?